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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A83by anterior cruciate ligament transection (ACLT) under general anes-
thesia, and 16 controls.Pre-operative radiographs of the femorotibial
joints were performed to exclude animals with pathology. Rabbits
were anesthetized and ACLT performed through a medial parapatellar
incision. Serumwas collected at -14 (baseline), 7, 14, 28, 42, 56, 70 and
84 days post-ACLT and aliquots were frozen at -20C until analysis.
Eight mL of the diluted thawed serum (1:1 in 4% KSCN) was placed in 5
mm diameter circular wells on an adhesive-masked silicon micro-
plate. Once dry, the microplate was mounted in a Fourier-transform
infrared spectrometer (FTIR; Tensor 37, Bruker Optics, Milton, Canada)
for the acquisition of IR absorbance spectra (400-4000 cm-1). For
each acquisition, 512 interferograms were signal averaged and Fourier
transformed to generate a spectrum with a nominal resolution of 4
cm-1. Spectra generated from each sample were averaged, differ-
entiated and smoothed to resolve and enhance weak spectral features
and to remove variation in baselines, using spectral manipulation
software. Following preprocessing, partial least squares discriminant
analysis (PLS-DA) was applied to the IR spectra at each time point
using script written in MatLab®. Variables contributing to the sepa-
ration of groups were selected using t-statistic, PLS weights and
regression coefﬁcients. Monte-Carlo methods were employed to
determine the empirical signiﬁcance of variables for separating
groups, by randomly permuting the class membership 5000 times to
obtain null distributions, and comparing the observed statistic for
each variable with the null distribution. The PLS-DA optimal model
was considered valid for Q2 (one minus the ratio of the prediction
error sum of squares over the total sum of squares of the response
vector) values signiﬁcant at P < 0.05.
Results: Infrared spectroscopic spectra combined with a PLS-DA clas-
siﬁcation strategy, generated IR-based serum biomarker proﬁles that
successfully discriminated between ACLT and control rabbits. Differ-
ences were signiﬁcant at 7, 14, 28, 42, 56, 70 and 84 days post-ACLT. The
distribution of t-statistic, PLS weights and regression coefﬁcients varied
signiﬁcantly between time points, indicating the potential of the
approach for monitoring the progression of osteoarthritis.
Conclusions: “Multiplexed” approaches have emerged in recent years
for the identiﬁcation and veriﬁcation of novel OA biomarkers,
employing genomic, proteomic and metabolomic tools. Although IR
spectroscopy has been used for rheumatoid arthritis, this study is the
ﬁrst to employ IR spectroscopy and PLS-DA to screen serum for a bio-
marker signature reﬂective of OA, encompassing both known and
unknown markers of disease. The ideal biomarker approach should be
rapidly and simply performed, yield accurate results, identify pro-
gression,differentiate between early and late stages of disease, and use
small volumes of easily accessible body ﬂuid. The method described
here achieves many of these ideals with fewer technical and less
expensive infrastructure requirements than others. Nevertheless access
to a larger number of well characterized biological samples is required
for more extensive validation.
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Purpose: Fibuline3 is highly expressed in osteoarthritic cartilage and
inhibits angiogenesis and chondrocyte differentiation. It has been
demonstrated to interact with the tissue inhibitor of metalloprotease
(TIMP)-3, which is a matrix bound inhibitor of matrix metal-
loproteinases (MMPs) and stimulates the expression of TIMP-1 and
TIMP-3, but inhibits the expression and activities of MMP-2, MMP-3,
and MMP-9. In the present study, the association between three Fibu-
lin3 peptides identiﬁed by proteomics and the incidence of radio-
graphic and clinical knee osteoarthritis (OA) in middle-aged overweight
and obese women, free of radiographic and symptomatic knee OA at
baseline was tested.
Methods: Women between 50 and 60 years, with a BMI  27 kg/m2,
free of knee OA were recruited through their general practitioner. At
baseline, physical examination including serum collection was
performed and radiographs and questionnaires on knee complaintswere obtained. Using binary logistic regression, the association
between baseline concentration of Fibulin(Fib)3-1, Fib3-2 and Fib3-3
and incidence of clinical and radiographic knee OA after 30
months of follow-up was tested, adjusting for age, BMI, and other
potential covariates that were identiﬁed in multivariable regression
analyses.
Results: Baseline serum samples and follow-up measurements were
available for 242 women. Mean agewas 55.9 ± 3.2 years, mean BMI was
31.6 ± 3.6 kg/m2 and 70%was postmenopausal. All subjects were free of
clinical and radiographic knee OA at baseline, but 24% had a unilateral
K&L score of 1 and 33% bilaterally. Mild symptoms were present in 24%
and 17% of the subjects, uni- and bilaterally respectively. Baseline
concentrations of all Fib3 fragments were log-transformed for a normal
distribution and z-transformed for uniformity reasons. Correlation
coefﬁcients for the baseline concentrations of the three Fib3 fragments
ranged from 0.13 to 0.58. Neither of the concentrations of the three Fib3
fragments were associated with incidence of medial or lateral joint
space narrowing  1.0 mm. or incidence of K&L grade 2. All three Fib3
fragments were associated with incidence of the clinical and radio-
graphic ACR-criteria and Fib3-1 and Fib3-3 also with chronic pain at
follow-up (see ﬁgure). When adjusted for the other Fib3 peptide con-
centrations, only Fib3-1 was signiﬁcantly associated to the incidence of
the ACR criteria (OR 2.5 [1.0-6.2]) and chronic pain at follow-up (OR 2.6
[1.1-5.9]).
Conclusions: Baseline Fibulin3 concentrations are associated to the
incidence of clinical knee OA amongmiddle-aged overweight and obese
women. Therewith, they meet the criteria of a prognostic biomarker
according to the BIPED biomarker classiﬁcation for OA. Further vali-
dation of the Fibulin3 fragments seems warranted in order to better
distinguish subgroups of individuals at increased risk for knee OA
development.
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DETECTION OF CTXII IN THE RAT KNEE VIA MAGNETIC BIOMARKER
CAPTURE
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Purpose: Osteoarthritis (OA) biomarker development often begins
with rodent models; however, methods to recover OA biomarkers from
rodent joints are not ideal. In large human joints, synovial ﬂuid can be
aspirated for biomarker analysis, but synovial ﬂuid aspiration from a
rat knee is limited by complex joint geometries and small ﬂuid vol-
umes. Instead, saline is often used to lavage synovial ﬂuid from the
joint, but lavage has limitations, including: 1) Lavage ﬂuids dilute
biomarker concentrations; 2) Mixing saline with highly viscous
synovial ﬂuid is not trivial and verifying ﬂuids are well-mixed prior to
removal from the rodent knee is practically impossible; and 3) Esti-
mation of joint-level biomarker concentrations is susceptible to joint
effusion. To address these limitations, our group has developed a
magnetic nanoparticle-based technology to collect OA biomarkers
from synovial ﬂuid in situ, termed magnetic capture. Using polymeric
particles that contain superparamagnetic iron oxide nanoparticles
(SPIONs) and are surface-functionalized with a targeting molecule, OA
biomarkers can be magnetically collected from a rodent knee without
